ADOLOR

	Home Contact Us Careers Terms of Use Site Map
COMPANY INVESTOR INSIGHTS RESEARCH & DEVELOPMENT PRODUCT PRESS ROOM
	WELCOME TO ADOLOR a • do • lor (a - do - lôr) Latin - without pain Adolor Corporation: Committed to helping relieve the suffering of patients by discovering new compounds, developing new products and delivering advanced pain management therapies to the marketplace First approved product, ENTEREG® (alvimopan), launched in collaboration with GlaxoSmithKline in mid 2008 Major collaboration with Pfizer to develop and commercialize novel delta opioid receptor agonists for the treatment of pain
	© 2009 Adolor Corporation. All rights reserved.